Abstract
125I-labeled anti-TAG-72 antibodies were applied in radioimmunoguided surgery (RIGS) to remove gross and occult tumors. It is challenging to handle 125I-labeled materials. PET/CT image-guided surgery utilizes 18FDG to monitor the biochemical activity of the tumor and to integrate pre- and postoperative imaging for complete tumor removal. PET/CT image-guided surgery only detects later stage disease. Fluorescence image-guided surgery using anti-TAG-72 antibodies may provide opportunities for intraoperative cancer detection of both gross and occult tumors.
Original language | English |
---|---|
Pages (from-to) | 297-308 |
Number of pages | 12 |
Journal | Journal of surgical oncology |
Volume | 96 |
Issue number | 4 |
DOIs | |
State | Published - Sep 15 2007 |
Keywords
- CC49
- PET
- RIGS
- Surgery